Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date

Overview of attention for article published in OncoTargets and therapy, April 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 1 news story.

Transcriptional activator LAG-3 protein. (HTTPS://EN.WIKIPEDIA.ORG) Early in 2021 at the American Society of Clinical Oncology’s…